Ergoteles LLC Wave Life Sciences Ltd. Transaction History

Ergoteles LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$3.51 - $4.69 $73,359 - $98,021	20,900 New	20,900 $76,000
Q4 2022 Feb 14, 2023	SELL	$3.18 - $7.0 $379,971 - $836,416	-119,488 Reduced 72.72%	44,820 $313,000
Q3 2022 Nov 14, 2022	SELL	$2.37 - $4.28 $73,913 - $133,480	-31,187 Reduced 15.95%	164,308 $593,000
Q2 2022 Aug 12, 2022	BUY	$1.23 - $3.25 $240,458 - $635,358	195,495 New	195,495 $635,000

171

117M

148K

109K

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $882M
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.